BriaCell Therapeutics Corp. (BCTX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.95
- As of
Kresmion compiles this page from BCTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
BriaCell Therapeutics Corp. (BCTX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-K filed 2026-10-28.
See the full BCTX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for BCTX on one page. Preview it with sample data, then open it live with a free account.
Preview the BCTX dossierActive events for BCTX
- medium13F: new position
CITADEL ADVISORS LLC new position in BCTX
- mediumEarnings below estimates
Q2-2025: Missed consensus by 18.9% - EPS $-23.3 vs $-19.594 estimate
- mediumEarnings above estimates
Q3-2025: Beat consensus by 7.7% - EPS $-16.4 vs $-17.776 estimate
- mediumEarnings below estimates
Q4-2025: Missed consensus by 353.7% - EPS $-55.49 vs $-12.2311 estimate
- mediumEarnings above estimates
Q2-2026: Beat consensus by 47.2% - EPS $-2.58 vs $-4.8884 estimate
FREE, NO ACCOUNT
Every event on BCTX, as it fires
New filings, 13F moves and cross asset events on BCTX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, BCTX
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
BCTX's 10-K filed Oct 28, 2026 states:
There is substantial doubt about our ability to continue as a going concern.
Read the 10-K on SEC EDGAR Every company with a going concern statement
More data on BCTX
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in BCTX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on BCTX in the last 180 days.
Upstream: SEC EDGAR filings for BCTX
Kresmion, "BriaCell Therapeutics Corp. (BCTX) institutional holdings and SEC filings", data as of 2026-10-28, https://kresmion.com/research/BCTX. Upstream data: SEC EDGAR filings for BCTX.
Link to this data (HTML):
<a href="https://kresmion.com/research/BCTX">BriaCell Therapeutics Corp. (BCTX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow BCTX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to BCTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.